Skip to main content

Peer Review reports

From: Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre

Original Submission
7 Feb 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
30 Mar 2021 Reviewed Reviewer Report
4 Apr 2021 Reviewed Reviewer Report - Martin Bommer
4 Apr 2021 Reviewed Reviewer Report
26 Apr 2021 Author responded Author comments - Steven Grangé
Resubmission - Version 4
26 Apr 2021 Submitted Manuscript version 4
30 Apr 2021 Reviewed Reviewer Report
27 May 2021 Reviewed Reviewer Report
22 Jun 2021 Author responded Author comments - Steven Grangé
Resubmission - Version 5
22 Jun 2021 Submitted Manuscript version 5
23 Jun 2021 Author responded Author comments - Steven Grangé
Resubmission - Version 6
23 Jun 2021 Submitted Manuscript version 6
Publishing
1 Jul 2021 Editorially accepted
21 Jul 2021 Article published 10.1186/s12882-021-02470-3

You can find further information about peer review here.

Back to article page